Our current findings suggest for the first time that breast cancer–expressed ICAM-1 accounts for the susceptibility of breast cancer CTCs entrapped inside lung vessels to intravascular killing by these neutrophils, most probably as they circulate through these vessels. Here, ICAM1 is linked to breast cancer.